CLINICAL SIGNIFICANCE OF BAFF/BLyS AND APRIL IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS

CLINICAL SIGNIFICANCE OF BAFF/BLyS AND APRIL IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS

The present work is devoted to mechanisms of action of cytokines BAFF/BLyS and APRIL in immune inflammatory rheumatic diseases; correlation between the level of this cytokines and activity of rheumatic arthritis and systemic lupus erythematosus (SLE); impact of the biologic agents on the level of BA...

Full description

Bibliographic Details
Main Authors:	E. V. Suponitskya, E. N. Aleksandrova, E. L. Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2014-10-01
Series:	Научно-практическая ревматология
Subjects:	baff/blys april rheumatoid arthritis systemic lupus erythematosus genetically engineered biologic drugs
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1990

Similar Items

CLINICAL VALUE OF BAFF AND APRIL CONCENTRATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. A. Panafidina, et al.
Published: (2016-07-01)

Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab
by: Francesca Regola, et al.
Published: (2019-04-01)

Expression of BAFF, APRIL, and cognate receptor genes in lupus nephritis and potential use as urinary biomarkers
by: David Aguirre-Valencia, et al.
Published: (2020-01-01)

Role of telitacicept in the treatment of IgA nephropathy
by: Lijun Wu, et al.
Published: (2023-09-01)

The BAFF-APRIL System in Cancer
by: Md Ashik Ullah, et al.
Published: (2023-03-01)

B cells targeting therapy in the management of systemic lupus erythematosus
by: Wen Shi Lee, et al.
Published: (2020-01-01)

Prospects for anti-BLyS treatment of systemic lupus erythematosus
by: S. K. Solovyov, et al.
Published: (2019-06-01)

The interplay of IL-21 and BAFF in the formation and maintenance of human B cell memory
by: Jodi eKarnell, et al.
Published: (2012-01-01)

BlyS is up-regulated by hypoxia and promotes migration of human breast cancer cells
by: Zhu Jing, et al.
Published: (2012-03-01)

Renal Tissue Expression of BAFF and BAFF Receptors Is Associated with Proliferative Lupus Nephritis
by: Miguel Marín-Rosales, et al.
Published: (2022-12-01)

Characterization of B cells in lupus erythematosus skin biopsies in the context of different immune cell infiltration patterns
by: Luka de Vos, et al.
Published: (2022-11-01)

Inhibition of Membrane-Bound BAFF by the Anti-BAFF Antibody Belimumab
by: Christine Kowalczyk-Quintas, et al.
Published: (2018-11-01)

B-Cells and BAFF in Primary Antiphospholipid Syndrome, Targets for Therapy?
by: Lucas L. van den Hoogen, et al.
Published: (2022-12-01)

BAFF, APRIL, and their receptors: physiological role and involvement in the pathogenesis of chronic lymphocytic leukemia
by: Katarzyna Schab, et al.
Published: (2018-09-01)

BAFF, APRIL, and their receptors: physiological role and involvement in the pathogenesis of chronic lymphocytic leukemia
by: Katarzyna Schab, et al.
Published: (2018-09-01)

Expression of BAFF and BR3 in patients with systemic lupus erythematosus
by: J.H. Duan, et al.
Published: (2016-03-01)

Bioinformatic Prediction of miRNAs Targeting APRIL and BAFF Genes in Chronic Lymphocytic Leukemia
by: Mahdieh Mondanizadeh, et al.
Published: (2019-11-01)

B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus
by: Francesca Romana Spinelli, et al.
Published: (2019-11-01)

Evaluation of BAFF, APRIL and CD40L in Ocrelizumab-Treated pwMS and Infectious Risk
by: Maria Antonella Zingaropoli, et al.
Published: (2023-04-01)

Profiling of B-Cell Factors and Their Decoy Receptors in Rheumatoid Arthritis: Association With Clinical Features and Treatment Outcomes
by: Javier Rodríguez-Carrio, et al.
Published: (2018-10-01)

B cell phenotype and serum levels of interferons, BAFF, and APRIL in multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C)
by: Adam Klocperk, et al.
Published: (2023-10-01)

Roles for BLyS family members in meeting the distinct homeostatic demands of innate and adaptive B cells
by: Michael P. Cancro, et al.
Published: (2013-02-01)

The impact of Epstein‐Barr virus latent membrane protein 2A on the production of B cell activating factor of the tumor necrosis factor family (BAFF), APRIL and their receptors
by: Kevin Madayag, et al.
Published: (2022-11-01)

Effect of BAFF blockade on the B cell receptor repertoire and transcriptome in a mouse model of systemic lupus erythematosus
by: Tao Huang, et al.
Published: (2024-01-01)

Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis
by: Justa Friebus-Kardash, et al.
Published: (2019-11-01)

Expression of B-cell activating factor, a proliferating inducing ligand and its receptors in primary central nervous system lymphoma
by: Tobias Birnbaum, et al.
Published: (2013-03-01)

Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapies.
by: Matthieu eMahévas, et al.
Published: (2013-12-01)

The role of BAFF and APRIL in IgA nephropathy: pathogenic mechanisms and targeted therapies
by: Chee Kay Cheung, et al.
Published: (2024-02-01)

BCMA (TNFRSF17) Induces APRIL and BAFF Mediated Breast Cancer Cell Stemness
by: Vasiliki Pelekanou, et al.
Published: (2018-08-01)

Patients opinion and adherence to antimalarials in lupus erythematosus and rheumatoid arthritis treatment
by: Renata Tavares de Souza Cabral, et al.
Published: (2020-04-01)

Pregnancy outcomes in patients with rheumatoid arthritis and systemic lupus erythematosus. Part I. Maternal outcomes
by: N. M. Kosheleva, et al.
Published: (2019-05-01)

Pregnancy outcomes in patients with rheumatoid arthritis and systemic lupus erythematosus. Part II. Neonatal outcomes
by: E. V. Matyanova, et al.
Published: (2019-07-01)

Neurological complications in systemic lupus erythematosus and rheumatoid arthritis
by: Agnieszka Damiza-Detmer, et al.
Published: (2018-12-01)

A Novel Pool of Microparticle Cholesterol Is Elevated in Rheumatoid Arthritis but Not in Systemic Lupus Erythematosus Patients
by: Shuaishuai Hu, et al.
Published: (2020-12-01)

Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis
by: Borja Hernández-Breijo, et al.
Published: (2022-09-01)

Kinetics of free and ligand-bound atacicept in human serum
by: Mahya Eslami, et al.
Published: (2022-12-01)

Metabolites and metabolic pathways associated with rheumatoid arthritis and systemic lupus erythematosus
by: Nancy P. Duarte-Delgado, et al.
Published: (2022-01-01)

Extracellular Vesicles in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Functions and Applications
by: Bo Zhang, et al.
Published: (2021-01-01)

Endothelial activation and injury by microparticles in patients with systemic lupus erythematosus and rheumatoid arthritis
by: Laura Atehortúa, et al.
Published: (2019-01-01)

Physical activity and sedentary behavior in patients with systemic lupus erythematosus and rheumatoid arthritis
by: Legge A, et al.
Published: (2017-11-01)